Literature DB >> 17596176

Men with Kennedy disease have a reduced risk of androgenetic alopecia.

R Sinclair1, K J Greenland, S van Egmond, C Hoedemaker, A Chapman, J D Zajac.   

Abstract

BACKGROUND: Spinal and bulbar muscular atrophy or Kennedy disease (KD) is an X-linked neurodegenerative disease caused by an expansion of a polymorphic tandem CAG repeat within the androgen receptor (AR) gene on chromosomal locus Xq11-q12. The CAG repeat region encodes a polyglutamine tract that, when expanded to above 40 in number, results in KD, a neurodegenerative disease primarily targeting lower motor neurones. KD is also associated with partial androgen insensitivity due to loss of receptor function. Degree of expansion of this repeat region, located in the first exon, is correlated with age at onset and disease severity. Androgenetic alopecia (AGA) is a polygenic trait also associated with functional polymorphism of the AR gene.
OBJECTIVES: To test whether partial loss of function in the AR gene associated with CAG polymorphism reduces the risk of AGA in affected men.
METHODS: Members of the Kennedy's Disease Association, an American-based support group, were invited to participate in an online survey to determine the age-related prevalence of AGA among men affected by KD. Data from 115 respondents with KD were compared with data from 654 white men of European descent in Maryborough, Australia.
RESULTS: The mean AGA score for men with KD was 1.64 (95% confidence interval, CI 1.41-1.87). The mean score for men in Maryborough was 2.82 (95% CI 2.71-2.93). The difference between the means was highly significant (P < 0.001), indicating thicker hair among the KD cohort. Treating AGA score as a continuous variable we found age to be highly significantly related to AGA score in men from Maryborough (P < 0.001) but not among men affected by KD (P = 0.90).
CONCLUSIONS: Men with KD have a reduced risk of AGA, likely to be due to a functional alteration in the AR caused by the polyglutamine expansion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596176     DOI: 10.1111/j.1365-2133.2007.08026.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  The clinical application of preimplantation genetic diagnosis for the patient affected by congenital contractural arachnodactyly and spinal and bulbar muscular atrophy.

Authors:  Linjun Chen; Zhenyu Diao; Zhipeng Xu; Jianjun Zhou; Wanjun Wang; Jie Li; Guijun Yan; Haixiang Sun
Journal:  J Assist Reprod Genet       Date:  2016-07-09       Impact factor: 3.412

Review 2.  The role of androgen and androgen receptor in skin-related disorders.

Authors:  Jiann-Jyh Lai; Philip Chang; Kuo-Pao Lai; Lumin Chen; Chawnshang Chang
Journal:  Arch Dermatol Res       Date:  2012-07-25       Impact factor: 3.017

Review 3.  Spinal and bulbar muscular atrophy: pathogenesis and clinical management.

Authors:  C Grunseich; C Rinaldi; K H Fischbeck
Journal:  Oral Dis       Date:  2013-05-09       Impact factor: 3.511

4.  Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.

Authors:  Christopher Grunseich; Ilona R Kats; Laura C Bott; Carlo Rinaldi; Angela Kokkinis; Derrick Fox; Ke-Lian Chen; Alice B Schindler; Ami K Mankodi; Joseph A Shrader; Daniel P Schwartz; Tanya J Lehky; Chia-Ying Liu; Kenneth H Fischbeck
Journal:  Neuromuscul Disord       Date:  2014-07-03       Impact factor: 4.296

5.  Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Authors:  Christopher Grunseich; Kristen Zukosky; Ilona R Kats; Laboni Ghosh; George G Harmison; Laura C Bott; Carlo Rinaldi; Ke-lian Chen; Guibin Chen; Manfred Boehm; Kenneth H Fischbeck
Journal:  Neurobiol Dis       Date:  2014-06-09       Impact factor: 5.996

6.  Do Genetic Alterations in Sex Steroid Receptors Contribute to Lacrimal Gland Disease in Sjögren's Syndrome?

Authors:  Stephen M Richards; David A Sullivan
Journal:  Open Endocrinol J       Date:  2009

7.  The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Authors:  Angela Rosenbohm; Susanne Hirsch; Alexander E Volk; Torsten Grehl; Julian Grosskreutz; Frank Hanisch; Andreas Herrmann; Katja Kollewe; Wolfram Kress; Thomas Meyer; Susanne Petri; Johannes Prudlo; Carsten Wessig; Hans-Peter Müller; Jens Dreyhaupt; Jochen Weishaupt; Christian Kubisch; Jan Kassubek; Patrick Weydt; Albert C Ludolph
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

Review 8.  Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells.

Authors:  Chawnshang Chang; Shuyuan Yeh; Soo Ok Lee; Ta-Min Chang
Journal:  Nucl Recept Signal       Date:  2013-08-19

9.  Minoxidil may suppress androgen receptor-related functions.

Authors:  Cheng-Lung Hsu; Jai-Shin Liu; An-Chi Lin; Chih-Hsun Yang; Wen-Hung Chung; Wen-Guey Wu
Journal:  Oncotarget       Date:  2014-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.